Oruka Therapeutics, Inc.: Form SC 13D, filed Apr 5, 2024
Filed with the SEC on Apr 5, 2024 and accepted by EDGAR at Apr 5, 2024, 16:05 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000902664-24-002769. Last ingested by Listed: Oct 26, 2026, 08:01 ET. Listed shows no prices and gives no investment advice.